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We used a cost-effective, non-invasive method to obtain high-quality DNA from buccal epithelial-cells
(BEC) of premature infants for genomic analysis. DNAs from BEC were obtained from premature
infants with gestational age # 36 weeks. Short terminal repeats (STRs) were performed simultaneously
on DNA obtained from the buccal swabs and blood from the same patient. The STR profiles
demonstrated that the samples originated from the same individual and exclude any contamination by
external DNAs. Whole exome sequencing was performed on DNAs obtained from BEC on premature
infants with and without necrotizing enterocolitis, and successfully provided a total number of reads
and variants corroborating with those obtained from healthy blood donors. We provide a proof of
concept that BEC is a reliable and preferable source of DNA for high-throughput sequencing in
premature infants.

U

nderstanding the genetic basis of a disease has vast potential benefit to healthcare. Obtaining genetic
material for analysis is thus essential and has broad implications for understanding the pathogenesis of
disease and for potentially designing individualized therapies. To this end, building repositories of genetic
material may prove to be a useful tool. Several molecular genetic tests can be performed using dried blood spots, as
is the case with statewide newborn screens. Other, more extensive testing, such as chromosome analysis, FISH
(fluorescent in situ hybridization), microarray and PCR-based genotyping assays require whole blood samples.
However, blood sampling is invasive, expensive and with limitations in preterm neonates. For these infants, every
milliliter of blood is significant, and relatively small volumes can constitute a large percentage of total blood
volume. Additionally, obtaining blood for laboratory analysis may cause pain or discomfort and should only be
collected when absolutely necessary.
The use of innovative and minimally invasive practices in pediatric and neonatal populations remains important. Buccal cells have previously been discredited as a source of reliable DNA in neonates, due to maternal
epithelial cell contamination1–4. The purpose of this study is to evaluate the efficacy of already tried-and-tested
buccal swab method to obtain high-quality DNA for high-throughput genomic analysis. This analysis includes:
short tandem repeat (STR) analysis, Taqman Allelic Discrimination Assay, Single Nucleotide Polymorphisms
(SNPs) genotyping by PCR-RFLP, and more importantly whole exome sequencing (WES).

Results
Genomic DNA was successfully isolated from all samples (170 buccal brushes from 85 patients and 61 whole
blood samples). Thirty-five (41%) premature neonates were extremely low birth weight, 33 (39%) were very low
birth weight and 14 neonates (16.5%) were considered as low birth weight (Table 1). High quality DNA was
obtained from buccal epithelial cells (BEC) with an average concentration 255.22 ng/mL (range: 89.5 to 421 ng/ml)
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Table 1 | Patient Demographic and Gestational Age and Birth
Weight in premature infants
Gestational age (weeks)
24 1/2 2
28 1/2 2
32 1/2 2
34–36

Birth Weight (kg)

Patients (N 5 85)

0.5–0.9
0.6–1.7
1.0–1.8
2.6–2.8

35
33
14
3

DNA from the buccal swabs was obtained from thirty five (41%) premature infants with extremely
low birth weigh (,1 kg), 33 (39%) with very low birth weight and 14 (16.5%) with low (low birth
weight (,2 kg).

and from whole blood (WB) (34.43 ng/ml; range 5.5 to 182.8 ng/ml).
Interestingly, the DNA yield from BEC, per set of experiments, was
significantly higher than WB (p # 0.0001).
To confirm that the DNAs obtained from BEC are free of any
external DNA contamination, we performed the STR (Short
Terminal Repeat) on 12 DNA pairs (12 BEC and 12 WB) using
AmpFlSTRH Plus and the results were analyzed by GeneMarker 2.4
(Softgenetics, PA). Full, single source profiles were obtained from all
samples and the profile of each BEC sample matched at all 15 loci and
Amelogenein with the WB sample from the same individual (Figure 1).
These results confirmed that the DNA obtained from the buccal swabs
was not contaminated by any external DNAs (Supplementary Table S1
online). Concomitantly, the same 12 DNA pairs were tested using six

TaqMan Probe-based Allelic discrimination assays for detection of
single nucleotide polymorphisms (SNPs). Data from genetic profiles
obtained from BEC corroborate 100% with those obtained from WB
cells (Supplementary Table S2 online). We then used these DNAs to
amplify a 485 bp sequence in the regulatory region of the TRIM21 gene
containing the polymorphic Bgl II site (C/T). PCR-RFLP reactions
were successfully performed for all DNA from BEC samples
(Supplementary Figure S1 online).
Whole exome sequencing is the state-of-art means of genomic
analysis. In an effort to evaluate whether the quality of the buccal
epithelial cell DNA in healthy and pathological cases were adequate
for next generation DNA sequencing technologies, we performed
whole exome sequencing on four samples: two healthy premature
infants and two infants with necrotizing enterocolitis (Bell’s Stage
III). The total number of reads for the controls #1, #2 and patients #1
and #2 were respectively 18,448,882, 24,206,718, 16,874,844 and
31,507,076. The average coverage was evaluated at 17.13. The total
number of coding variants discovered that passed analysis parameters was 18,649 6 1,781 (Table 2). Our data corroborate with
laboratory results obtained from the whole blood of healthy donors
(unpublished data) and other previously published studies5,6
Our data provides the proof of concept that an already tried-andtested buccal swab method is a reliable, inexpensive, non-invasive
and suitable for biobanking of genomic materials. The DNA from
BEC meets quantitative and qualitative requirements for highthroughput screening and next generation sequencing technologies.

Figure 1 | Electropherogram of four STR loci. The electropherogram of STRs were obtained from the amplification of WB (A) and BEC (B) samples.
Across the profile two or less alleles are present at each locus and peak height ratio, between sister alleles at heterozygous loci, is within the expected rage
indicating that both are single source samples (i.e. absence of contamination). The two profiles are an exact match demonstrating that the samples
originated from the same individual.
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Table 2 | Whole Exome Sequencing (WES)

Total Variants
Missense
Nonsense
Frameshift Insertion/Deletion
Synonymous
Splicing
Non-frameshift Insertion/
Deletion
Total Variants

Control #1

Control #2

Patient #1

Patient #2

Healthy Donor*

8,541
72
78
10,738
157
145

8,411
60
86
10,340
158
133

8,417
71
82
10,764
173
166

7,007
61
63
8,598
134
139

7,927
59
81
9,444
195
169

19,731

19,188

19,673

16,002

17,875

DNA from BEC were used to perform WES. DNA from either healthy premature infants (Controls) or premature infants with necrotizing enterocolitis (Patients) showed comparable results indicating the
adequacy of the quality and quantity of DNA obtained from buccal swabs for genomic analysis. *WES data from the BEC are comparable with those obtained from healthy blood donor (unpublished data).

Discussion
Our cohort of eighty-five premature infants is larger than any previously published studies on the use of BEC for DNA extraction in this
population and is the only one focused exclusively on premature
infants7–12.
Although whole blood samples provide generous amounts of good
quality DNA, its collection remains invasive, expensive and technical
difficulties associated with phlebotomy in small, sick preterm neonates often limit the volume of blood obtained and therefore, reduce
the possibility of genomic testing. Phlebotomy from a neonate
requires a skilled practitioner and the use of a large number of
DNA purification columns (7 to 8 purification columns for 750 ml
of blood), which significantly increases the cost and the extraction
time. In addition, blood drawing, placement of peripheral and central
vascular catheters, can cause pain and discomfort, compromise the
skin integrity and increase the risk of infection in premature neonates. Alternatively, BEC can be collected by any trained member of a
clinical care or research team and does not require the use of a
particular extraction kit, reducing the overall cost and does not
increase the odds of the infection associated with venipuncture.
Research dedicated to advancing the care of premature neonates
has necessitated investigation into reliable sources of genomic
DNA. This study successfully validated the use of BEC as a noninvasive and reliable source of genomic DNA for use in a variety of
genetic assays.
The issue of possible contamination always remains paramount.
STR is a reliable method to determine whether or not any contamination with external DNA exists. To confirm the BEC and blood
samples were from the sample individual, we utilized STR analysis of
matched BEC and blood samples from 12 patients. Historically, the
STR analysis has been used to ensure that a prenatal fetal sample is
not contaminated with maternal cells prior to assaying the prenatal
fetal sample13. Therefore, it constitutes a very sensitive method able
to detect the DNA from single cell. All 15 STR loci and amelognein
showed similar profile between the matched BEC and blood samples.
This demonstrates there was not any contamination of the BEC and
blood samples by maternal or any other DNA.
While the use of BEC for genomic DNA is not a novel method, we
successfully showed that the improved methodology can be used for
genetic analysis and the state-of-art genomic technology such as
whole exome sequencing.
The collection of DNA from BEC provides high quality and quantity DNA for genomic studies. Furthermore, it will allow for easy resampling in premature or newborn infants if an assay fails.
Methods and Patients
Patient selection. Following Institutional Review Board approval protocol at
Children’s National Health system, parental consent were obtained from all patients
with a gestational age of less than 36 weeks included in this study. Preterm infants
were recruited at the Neonatal Intensive Care Unit (NICU) at Children’s National
Health System, a 54 bed, level IV NICU. All enrolled patients were Nil Per Os (NPO)
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at the time of buccal swab and blood collection. Patient demographics are represented
in Table 1.
Sample collection and DNA extraction. Buccal swabs were collected from 85
patients with a gestational age ranging from 24–36 weeks using cytology brushes.
Briefly, 2 brushes were twirled on the inside of each cheek for less than 10 seconds.
0.75 mL of blood was also collected from 61 patients. DNA was extracted from blood
or buccal swab specimens using Qiagen Buccal Cell and DNAeasy Kit (Qiagen
Sciences, MD) respectively. We modified the buccal cell extraction kit for each
experiment set to accommodate a three-fold increase in sample processing for a cell
lysate volume of 900 mL. 100 mL of whole blood in EDTA was used for DNA
extraction, corresponding to the recommended upper volume limit by the Qiagen
DNA extraction kit for one set of experiments.
Short tandem repeat (STR) analysis. DNAs were diluted to a final concentration of
0.5 ng/mL. One mL of each samples was amplified with AmpFlSTRH IdentifilerH Plus
(Applied Biosystems) with 2 mL of reaction mix, 1 mL of primer mix, 1 mL dH2O in a
5 mL final volume. The amplification cycle was 11 min. at 95uC, 283(20 sec. at 94uC,
3 min. at 59uC), 10 min at 60uC, ‘ at 4uC. To prepare samples for electrophoresis,
10 mL of LIZ 120 size standard was added to 400 mL of Hi-Di formamide (Applied
Biosystems), and 1 mL of sample was added to 10 mL of the Formamide/ILS mixture.
The AmpFlSTRH IdentifilerH Plus kit contains 15 STR systems (D8S1179, D21S11,
D7S820, CSF1PO, D3S1358, TH01, D13S317, D16S539, D2S1338, D19S433, VWA,
TPOX, D18S51, D5S818 and FGA). Samples were electrophoresed on the 3130
Genetic Analyzer (Applied Biosystems), using a 36 cm capillary and POP-7 polymer
with injection parameters of 1.2 kV for 16 s. STR fragment analysis was GeneMarker
2.4 (Softgenetics, PA).
Taqman Probe-based assay. 10 ng of DNA obtained from the buccal swabs and
whole blood were analyzed for six SNPs (rs1799983 [C___3219460_20], rs854560
[C___2259750_20], rs1137101 [C___8722581_10], rs1815739 [C____590093_1_],
rs1046502 [C___7577769_10], and rs4871385 [C__12060045_20) according to the
manufacturer’s protocol (Life Technologies, CA). Briefly, this method employs the 5’
nuclease activity of Taq polymerase to detect a fluorescent reporter signal generated
during PCR reactions. Data were collected on a Life Technologies 7900HT Sequence
Detection System and analyzed using the SDS 2.4 software.
PCR-restriction fragment length polymorphism (PCR- RFLP) analysis. 200 ng of
BEC DNA from 85 premature infants were subject to PCR using 59 CTG TAC ATC
CAC AGT GAG C 39 (Forward primer) and 59 CAT CCC TTG TCA GAT GGA TAG
39 (Reverse primer). The PCR products were then digested with the restriction
enzyme Bgl II (New England BioLabs, MA) to determine a polymorphism in the
TRIM21 gene according to previously published data14,15.
Genomic DNA quantification and quality assessment. Quality of genomic DNA
was assessed by 1% agarose gel. Samples that pass the gel check proceed to
quantification using Qubit 2.0 Fluorometer using QubitH dsDNA BR Assay Kits
(Invitrogen, CA).
Illumina DNA library preparation. DNA library preparation was completed using
Illumina’s TruSeq DNA Sample Prep v2 kit protocol (Illumina, CA). The DNA (1 mg)
was randomly fragmented by the Covaris S220 (Covaris, MA) using insert sizes of 100
to 900 bp. DNA quality was checked by analysis of samples on the Agilent 2100
Bioanalyzer using a DNA High Sensitivity chip followed by quantification on the
Qubit 2.0 Fluorometer (Life Technologies).
Exome enrichment was carried out using the standard protocol for the Illumina
TruSeq Exome Enrichment Kit (Illumina, CA). Combining 500 ng from each sample
creates library pools (only samples with different index adapters were pooled
together). Following the Illumina Trueseq Exome Enrichment protocol, the quality of
the final libraries is checked using an Agilent High Sensitivity DNA Bioanalyzer chip
(Agilent, CA). The libraries are then quantified using the Qubit 2.0 Fluorometer and
normalized to 1 ng/ul.
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Quantative PCR (qPCR). The Kapa Biosystems Library Quantification Kit-Illumina/
ABI Prism kit is used for the qPCR (Kapa Biosystems, MA). The quality of the final
libraries are checked using an Agilent High Sensitivity DNA Bioanalyzer chip
(Agilent, CA). The libraries are quantified using the Qubit 2.0 Fluorometer and the
libraries are normalized to 1 ng/ul. The qPCR is performed on the normalized library
with a Life Technologies 7900HT Real Time PCR System to determine the
concentration. All of the libraries are pooled together and normalized to single
concentration (4 nM). For the HiscanSQ analysis seven pools were created has and
each pool has four samples for a total of 28 samples. qPCR is performed on the library
pools using the ABI 7900HT Fast Real Time PCR System to validate the final
concentration. Thermal cycling parameters were as follows: with the following
conditions: 95uC for 5 minutes followed by 35 cycles of 95uC for 30 seconds, 60uC for
30 seconds.
Illumina cluster generation and sequencing. The Illumina cBot was used to
hybridize the libraries to the flowcell and generate clusters. The flowcell was then
loaded onto the Illumina HiScan along with the TruSeq SBS v3 200 cycle kit (Illumina,
CA) and ran on a 101 3 7 3 101 paired end single multiplexed program. The exome
sequencing analysis took approximately 10 days to finish.
Genome analysis tool kit for exome analysis. We sequenced four samples on one
lane on an Illumina HiScanSQ system, aligned the resulting reads to the hg19
reference genome with Burrows-Wheeler alignment (BWA)16, applied the genome
analysis tool kit (GATK)17 base quality score recalibration, insertion/deletion
realignment, duplicate removal, and performed SNP and insertion-deletion18
discovery and genotyping across all four samples simultaneously using standard hard
filtering parameters or variant quality score recalibration19.
Statistical analysis. A student’s two-tailed t-test was used to compare yields between
whole blood and buccal cells.
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